These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 8440164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Omeprazole: a comprehensive review.
    Massoomi F, Savage J, Destache CJ.
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [Abstract] [Full Text] [Related]

  • 6. Omeprazole.
    Walan A.
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):629-40. PubMed ID: 3048454
    [No Abstract] [Full Text] [Related]

  • 7. Omeprazole and acid peptic disease.
    Piper DW, Yeomans ND, Shearman DJ.
    Med J Aust; 1991 Mar 18; 154(6):374-5. PubMed ID: 2000048
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A.
    J Gastroenterol Hepatol; 1989 Mar 18; 4 Suppl 2():27-33. PubMed ID: 2491359
    [Abstract] [Full Text] [Related]

  • 10. Omeprazole.
    Maton PN.
    N Engl J Med; 1991 Apr 04; 324(14):965-75. PubMed ID: 2002819
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Martín de Argila C, Boixeda de Miquel D, Moreira Vicente V, García Plaza A.
    Rev Clin Esp; 1999 Nov 04; 199(11):729-39. PubMed ID: 10638238
    [No Abstract] [Full Text] [Related]

  • 15. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
    Lamers CB.
    Digestion; 1989 Nov 04; 44 Suppl 1():92-5. PubMed ID: 2691316
    [Abstract] [Full Text] [Related]

  • 16. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
    Bium AL.
    Digestion; 1989 Nov 04; 44 Suppl 1():87-91. PubMed ID: 2691314
    [Abstract] [Full Text] [Related]

  • 17. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
    Meijer JL, Jansen JB, Lamers CB.
    Digestion; 1989 Nov 04; 44 Suppl 1():31-9. PubMed ID: 2575060
    [Abstract] [Full Text] [Related]

  • 18. Cimetidine: appropriate uses in 1980.
    Knudson KB, Dyck WP.
    Tex Med; 1980 May 04; 76(5):35-6. PubMed ID: 7385070
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G, Amplaz S, Benvenuti S, Bertozzo A.
    G Clin Med; 1990 May 04; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.